Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onapristone in Advanced CRPC
NCT02049190Phase 2Unknown
- Sponsor
- Arno Therapeutics, Inc.
- Start
- Feb 2014
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of onapristone extended release in castration-resistant prostate cancer (CRPC), sponsored by Arno Therapeutics, Inc.. Status: unknown.
02
Drugs
onapristone extended release
03
Conditions
castration-resistant prostate cancer (CRPC)
Beyond the preview
Go deeper on NCT02049190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02049190.